An ipr case study about needles I guess

1. BY : Group 4
Amisha Gunderia
Manali Malavade
Srushti Gujjanwar
Sanskruti Mahajan

2.  For diabetes patients, daily injections are an uncomfortable and
often painful part of life. With multiple injections required every
day, anxiety and fear are typical emotions a patient may have when
diagnosed with diabetes, especially for children and those with a
fear of needles. Traditionally thought of as an unavoidable part of
treatment, injection therapy and the pain and discomfort it causes
has become one of the major concerns of diabetes patients.
 However, thanks to Terumo Corporation (Terumo), a Tokyo based
medical equipment manufacturer, this traditionally held view is
changing.

3.  The usual method of manufacturing needles is to hollow out a tiny
cylinder of metal. But it is extremely difficult to make ultra thin
needles this way, because the thinner the cylinder, the more difficult the
procedure becomes
 Terumo turned to Okano, a company whose skilled craftsmanship
boasts a high level of technology despite its small size. Working
together with Okano, Terumo was able to innovate the world’s thinnest
needle for insulin injections.
 The new syringe is marketed as the Nanopass 33 syringe and went on
to the market in July 2005.

4. The intellectual property rights were essentially recognized
and accepted all over the world due to some very important
reasons.
To provide an incentive to individuals for new creations
To accord due recognition to the creators and inventors
To ensure material reward for intellectual property
To make available genuine and original products.

5. Because Terumo is a multinational corporation at the
forefront of innovating new medical technologies, protecting
its intellectual property (IP) is an important part of its
business strategy. Securing IP rights (IPRs) deters copying
and gives the company a competitive advantage, allowing it
to continue to develop medical products that help people.

6. This innovation uses primarily 2 IPRs:
1. PATENT
2. TRADEMARK

7. PATENT:
 A patent is a type of intellectual property that gives its owner the legal
right to exclude others from making, using, or selling an invention for a
limited period of time in exchange for publishing an enabling disclosure
of the invention
 A patent is important because it can help safeguard your invention. It
can protect any product, design or process that meets certain
specifications according to its originality, practicality, suitability, and
utility. In most cases, a patent can protect an invention for up to 20
years. This time period starts soon as you file your patent.

8.  Terumo has filed an application under the Patent Cooperation Treaty
(PCT) system in 2003 (published in 2004) for its tapered and liquid
introducing injection needle. By 2010, the company had hundreds of
PCT applications.
Patented technology :
1. Slim double tapered shape
2. Asymmetrical bevel

9. Slim double tapered shape :
The slim double tapered shape reduces the pain during stinging and
bleeding, while holding down the insulin injection force significantly,
which usually increases as the diameter of the needle becomes smaller.
Thanks to the slim shape up to the base of the needle and the gentle
taper angle, the force applied to the needle is dispersed and the strength
is more easily achieved.

10. Asymmetric bevel:
Terumo has developed an asymmetric bevel that cuts the skin
instead of puncturing it. This effectively decreases penetration
resistance.

11. TRADEMARK:
 A trademark is a type of intellectual property consisting of a
recognizable sign, design, or expression that identifies products or
services from a particular source and distinguishes them from others.
The trademark owner can be an individual, business organization, or
any legal entity.
 Recognizable trademarks also help to build a brand’s reputation. An
effective trademark can influence the buying decisions of consumers
and bring to mind positive, powerful messages about your brand

12. The company also places an emphasis on protecting its
company and product names. It registered a trademark for
its company name and logo with the United States Patent
and Trademark Office (USPTO), which is an update to prior
registrations in the 1960s and 1980s.

13. Terumo’s innovative product has not only been a financial success for
the company, but it has also helped patients around the world lead
better lives. Protecting its IP for innovations such as the Nanopass 33
needle has given the company the freedom to continue to develop new
medical products and create new manufacturing processes that
reduce the end cost to the patient. Terumo has also capitalized on the
success of the Nanopass 33 needle to educate the public on diabetes
and dispel many of the myths surrounding the disease. The case of
Terumo and the Nanopass 33 needle is an example of a company
using R&D, innovation and IPRs to grow and make a positive social
impact.